ABSTRACT
. The effects of E2, P4, RU-486 on cell proliferation of BG-1 cells. BG-1 cells were seeded at 5000 cells/well in 96-well plates in the presence of phenol red-free DMEM (+5% CD-FBS). After 2 days, the medium was replaced by phenol red-free DMEM (+5% CD-FBS) containing (A) Estradiol (B) Progesterone and (C) RU-486 (mifepristone), a PR antagonist, at the indicated concentration for 4 days. The cell viability was determined by MTT assay. * P<0.05 compared to a vehicle. 
RESULTS
The results showed that P4 inhibited the migration and invasion activity of BG-1 ovarian cancer cells, which was increased by E2 via its receptor interaction. These alterations were also related with changes in the epithelial-mesenchymal transition (EMT) markers such as E-cadherin, Vimentin, and N-cadherin and EMTassociated transcriptional factors, Snail and Slug, too. Upon P4 stimulation, the expression of the epithelial marker E-cadherin was strikingly increased, whereas the expression of mesenchymal makers like N-cadherin and Vimentin was decreased. EMT-associated transcriptional factors, Snail and Slug, were also significantly down-regulated. These results indicate that P4 can inhibit the migration of BG-1 ovarian cancer cells by reducing EMT. Consequently, the present results represent that P4 is a potent substance which may inhibit the growth of human ovarian cancer cells and metastasis via regulation of PR. Therefore, the hormone therapy using P4 may be a clinically effective tool for the treatment of human epithelial ovarian cancer. 
CONCLUSIONS

